Division of Periodontology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Research Unit for Oral-Systemic Connection, Division of Oral Science for Health Promotion, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
J Periodontol. 2019 Oct;90(10):1160-1169. doi: 10.1002/JPER.18-0630. Epub 2019 May 9.
Periodontitis is an inflammatory disease that results in alveolar bone resorption due to inflammatory cytokine production induced by bacterial antigens such as lipopolysaccharides (LPS). Here, the preventive effect of the Amyl-1-18 peptide derived from rice in an experimental model of periodontitis and the effect on the anti-inflammatory response were assessed.
Alveolar bone resorption, gene transcription of proinflammatory cytokines in the gingiva, and the endotoxin level in the oral cavity were evaluated after oral administration of the Amyl-1-18 peptide for 14 days using a ligature-induced periodontitis model in mice. Additionally, murine macrophages were incubated with LPS of Escherichia coli or Porphyromonas gingivalis in the presence of Amyl-1-18 to analyze the suppressive effects of Amyl-1-18 on the cell signaling pathways associated with proinflammatory cytokine production, including inflammasome activities.
Oral administration of Amyl-1-18 suppressed alveolar bone resorption and gene transcription of interleukin (il)6 in the gingiva of the periodontitis model, and decreased endotoxin levels in the oral cavity, suggesting modulation of periodontal inflammation by inhibition of endotoxin activities in vivo. Also, Amyl-1-18 suppressed IL-6 production induced by LPS and recombinant IL-1β in macrophages in vitro but had no effect on inflammasome activity.
The Amyl-1-18 peptide from rice inhibited alveolar bone destruction in mouse periodontitis model via suppressing inflammatory cytokine production induced by LPS. It was suggested that Amyl-1-18 peptide has anti-inflammatory property against LPS, not only by neutralization of LPS and subsequent inhibition of nuclear factor-κB signaling but also by inhibition of the IL-1R-related signaling cascade.
牙周炎是一种炎症性疾病,由于细菌抗原(如脂多糖 [LPS])诱导的炎症细胞因子产生,导致牙槽骨吸收。在此,评估了源自大米的 Amyl-1-18 肽在牙周炎实验模型中的预防作用及其对抗炎反应的影响。
使用结扎诱导的牙周炎小鼠模型,在口服 Amyl-1-18 肽 14 天后,评估牙槽骨吸收、牙龈中促炎细胞因子的基因转录和口腔内内毒素水平。此外,在 LPS 或 Porphyromonas gingivalis 的存在下,将鼠巨噬细胞与 Amyl-1-18 孵育,以分析 Amyl-1-18 对与促炎细胞因子产生相关的细胞信号通路的抑制作用,包括炎症小体活性。
口服 Amyl-1-18 抑制牙周炎模型中牙龈的牙槽骨吸收和白细胞介素(IL)6 的基因转录,并降低口腔内的内毒素水平,表明体内通过抑制内毒素活性调节牙周炎症。此外,Amyl-1-18 抑制了 LPS 和重组 IL-1β在体外诱导的巨噬细胞中 IL-6 的产生,但对炎症小体活性没有影响。
源自大米的 Amyl-1-18 肽通过抑制 LPS 诱导的炎症细胞因子产生抑制了小鼠牙周炎模型中的牙槽骨破坏。提示 Amyl-1-18 肽具有抗炎作用,不仅通过中和 LPS 并随后抑制核因子-κB 信号通路,而且通过抑制 IL-1R 相关信号级联反应。